Skip to main content

Table 1 Patient demographics and tumour characteristics

From: Management of patients with early stage lung cancer – why do some patients not receive treatment with curative intent?

SubgroupMāoriNon-MāoriP-value (Chi-square test)Total
Sex
 Female104 (61.5%)220 (53.1%)0.064324 (55.6%)
 Male65 (38.5%)194 (46.9%) 259 (44.4%)
Age (years)
  < 6035 (20.7%)53 (12.8%)< 0.00188 (15.1%)
 60–6965 (38.5%)120 (29.0%) 185 (31.7%)
 70–7957 (33.7%)170 (41.1%) 227 (38.9%)
 80+12 (7.1%)71 (17.1%) 83 (14.2%)
Smoking status
 Current smoker63 (40.4%)104 (27.0%)< 0.001167 (30.9%)
 Ex-smoker91 (58.3%)234 (60.8%) 325 (60.1%)
 Never smoked2 (1.3%)47 (12.2%) 49 (9.1%)
 Unknown1329 42
Charlson Comorbidity
 037 (21.9%)119 (28.7%)< 0.001156 (26.8%)
 144 (26.0%)147 (35.5%) 191 (32.8%)
 251 (30.2%)99 (23.9%) 150 (25.7%)
 329 (17.2%)33 (8.0%) 62 (10.6%)
 4+8 (4.7%)16 (3.9%) 24 (4.1%)
COPD
 No57 (39.9%)207 (57.2%)< 0.001264 (52.3%)
 Yes86 (60.1%)155 (42.8%) 241 (47.7%)
 Unknown2652 78
Cell type
 NSCLC124 (91.2%)328 (96.2%)< 0.001452 (94.8%)
 Others2 (1.5%)9 (2.6%) 11 (2.3%)
 Small cell10 (7.4%)4 (1.2%) 14 (2.9%)
 Unknown3373 106
FEV1
  < 50%46 (30.3%)63 (17.4%)< 0.001109 (21.2%)
 50%~ 80%70 (46.1%)139 (38.4%) 209 (40.7%)
 80%+36 (23.7%)160 (44.2%) 196 (38.1%)
 Unknown1752 69
ECOG
 051 (32.3%)157 (40.6%)0.194208 (38.2%)
 173 (46.2%)158 (40.8%) 231 (42.4%)
 2+34 (21.5%)72 (18.6%) 106 (19.4%)
 Unknown1127 38
Total169414 583